GSK access director makes Mundipharma move

Jerome Moreau (pictured above), director for global market access and pricing at UK pharma major GlaxoSmithKline (LSE: GSK), has taken on a new role at Mundipharma.

Mr Moreau has been named head of market access at Mundipharma, a UK-headquartered network of privately-owned independent associated companies with a portfolio covering areas that range from diabetes to oncology, respiratory disorders, pain and biosimilars.

At GSK, his role focused on a global strategy for access and pricing across the chronic obstructive pulmonary disorder franchise and local operating companies, while before that, he worked in France for Swiss pharma giant Novartis (NOVN: VX) as senior expert of strategic operations, market access and public affairs.